Dr. Gemma Moiset is a Senior Group Leader of Advanced Modalities at Charles River Laboratories in Leiden, The Netherlands. She leads the Cell Therapy and Antibody team contributing to early-stage research and discovery programs for novel drug therapies such cell therapies and therapeutic antibodies. Formerly, she worked in Biotech contributing to the development of monoclonal antibodies against cancer from discovery towards IND submission. Prior to that, she was a post-doctoral fellow at the Netherlands Cancer Institute. Dr. Gemma Moiset has a combined background in immunology, cellular biology and medicinal chemistry. She holds a PhD in Life Sciences from the University of Groningen and Zernike Institute for Advanced Materials.